Sware
Sware include quality management implementation and remediation, risk management, auditing and training, computer systems validation, and many more, enabling clients to get product efficiency and cost reduction through the systems implementation process and integrated compliance ecosystem methodology.
$6M
Latest Funding
Series B
Latest Funding Stage
2024-06-07
Funding Date
74
Employees
United States
Location
Chelsea, Massachusetts
City & State
Sales-Ready Summary
Sware recently raised $6M in Series B funding and utilizes HubSpot for their CMS, marketing automation, and analytics, making them a high-intent prospect for vendors offering complementary tools or services that integrate with the HubSpot ecosystem.
Key Contacts
Open Positions
View Careers PageHiring For
Similar Startups
Archipelo
The Archipelo Developer Security Posture Management Platform provides organizations with—the underlying system of record to capture SDLC event data tied to developer actions. Archipelo empowers security, GRC, and engineering teams to proactively identify, triage, and mitigate risks before they impact your business.
Workhelix
Workhelix brings together advanced research and comprehensive data to assess organizations' generative AI opportunities and which tasks can be accelerated with available technology, enabling businesses to navigate the opportunity landscape with data and reports, rather than relying on gut and instinct.
Subscript
Subscript is a platform that allows users to develop, understand, and manage subscription businesses. This enables members to update the database, calculate measures such as ARR, net revenue retention, CAC, LTV, ARPA, and so on, and analyze customer segments.
Eikon Therapeutics
Eikon Therapeutics is a biopharmaceutical company that focuses on developing innovative technologies for drug discovery. The company utilizes advanced live-cell resolution microscopy and engineering to identify and create new therapeutic candidates. Eikon Therapeutics aims to enhance the understanding of biological processes at a cellular level,supporting targeted treatment development.